Editorial
| Rev Diabet Stud,
2004,
1(2):55-57 |
DOI 10.1900/RDS.2004.1.55 |
Will C-Peptide Substitution Make a Difference in Combating Complications in Insulin-Deficient Diabetes?
Anders A.F. Sima
Departments of Pathology and Neurology, Wayne State University, 540 E. Canfield Avenue, Detroit, MI 48201, USA, e-mail: asima@med.wayne.edu.
Abstract
n/a
Fulltext:
 HTML
,  PDF
(157KB)
This article has been cited by other articles:
|
Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin
Meyer JA, Subasinghe W, Sima AA, Keltner Z, Reid GE, Daleke D, Spence DM
Mol Biosyst 2009. 5:1157-1162
|
|
|
Rosuvastatin positively changes nerve electrophysiology in diabetic rats
Tarhzaoui K, Valensi P, Leger G, Cohen-Boulakia F, Lestrade R, Behar A
Diabetes Metab Res Rev 2009. 25(3):272-278
|
|
|
